DAVID W. OSBORNE

Insider Reports History

Signature
/s/ Scott Burrows, as Attorney-in-Fact for David W. Osborne, Ph.D.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by DAVID W. OSBORNE:

Company Role Class Num Shares Value Price $ Report Date Ownership
Arcutis Biotherapeutics, Inc. Chief Technical Officer Common Stock 268,854 $951,958 $3.54 06 Mar 2023 Direct
Arcutis Biotherapeutics, Inc. Chief Technical Officer Stock Option (Right to Buy) 39,500 02 Mar 2023 Direct

Insider Reports Filed by DAVID W. OSBORNE

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ARQT Arcutis Biotherapeutics, Inc. 06 Mar 2023 1 -$10,532 4 Chief Technical Officer 08 Mar 2023, 15:26
ARQT Arcutis Biotherapeutics, Inc. 02 Mar 2023 2 $0 4 Chief Technical Officer 06 Mar 2023, 17:56
ARQT Arcutis Biotherapeutics, Inc. 28 Feb 2023 3 -$32,002 4 Chief Technical Officer 02 Mar 2023, 18:03
ARQT Arcutis Biotherapeutics, Inc. 08 Jul 2022 1 -$55,835 4 Chief Technical Officer 12 Jul 2022, 19:30
ARQT Arcutis Biotherapeutics, Inc. 21 Apr 2022 1 -$44,872 4 Chief Technical Officer 21 Apr 2022, 18:32
ARQT Arcutis Biotherapeutics, Inc. 03 Mar 2022 4 -$14,420 4 Chief Technical Officer 07 Mar 2022, 19:47
ARQT Arcutis Biotherapeutics, Inc. 01 Mar 2022 1 -$13,758 4 Chief Technical Officer 03 Mar 2022, 15:18